Marcus Laird Forrest, Ph.D. - Publications

Affiliations: 
2003 University of Illinois, Urbana-Champaign, Urbana-Champaign, IL 
 2007- Pharmaceutical Chemistry University of Kansas, Lawrence, KS, United States 
Area:
Oncology, Pharmacy, Nanotechnology
Website:
https://pharmacy.ku.edu/people/laird-forrest

68 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Ishiguro S, Cai S, Uppalapati D, Turner K, Zhang T, Forrest WC, Forrest ML, Tamura M. Intratracheal Administration of Hyaluronan-Cisplatin Conjugate Nanoparticles Significantly Attenuates Lung Cancer Growth in Mice. Pharmaceutical Research. PMID 27335023 DOI: 10.1007/s11095-016-1976-3  1
2016 Kuehl C, Zhang T, Kaminskas LM, Porter CJ, Davies NM, Forrest ML, Berkland CJ. Hyaluronic Acid Molecular Weight Determines Lung Clearance and Biodistribution after Instillation. Molecular Pharmaceutics. PMID 27157508 DOI: 10.1021/acs.molpharmaceut.6b00069  0.48
2016 Zhang T, Cai S, Groer C, Forrest WC, Yang Q, Mohr E, Douglas J, Aires D, Axiak-Bechtel SM, Selting KA, Swarz JA, Tate DJ, Bryan JN, Forrest ML. Hyaluronan-Lysine Cisplatin Drug Carrier for Treatment of Localized Cancers: Pharmacokinetics, Tolerability, and Efficacy in Rodents and Canines. Journal of Pharmaceutical Sciences. PMID 27155765 DOI: 10.1016/j.xphs.2016.03.018  1
2015 Zhang T, Yang Q, Forrest WC, Cai S, Aires D, Forrest ML. A Lanthanum-Tagged Chemotherapeutic Agent HA-Pt to Track the In Vivo Distribution of Hyaluronic Acid Complexes. Baoj Pharmaceutical Sciences. 1. PMID 26756040  0.36
2015 Sim MW, Grogan PT, Subramanian C, Bradford CR, Carey TE, Forrest ML, Prince ME, Cohen MS. Effects of peritumoral nanoconjugated cisplatin on laryngeal cancer stem cells. The Laryngoscope. PMID 26690734 DOI: 10.1002/lary.25808  1
2015 Yang Q, Gong M, Cai S, Zhang T, Douglas JT, Chikan V, Davies NM, Lee P, Choi IY, Ren S, Forrest ML. Combining hard and soft magnetism into a single core-shell nanoparticle to achieve both hyperthermia and image contrast. Therapeutic Delivery. 6: 1195-210. PMID 26606855 DOI: 10.4155/tde.15.68  1
2015 Chakraborty A, Mucci NJ, Tan ML, Steckley A, Zhang T, Forrest ML, Dhar P. Phospholipid composition modulates carbon nanodiamond-induced alterations in phospholipid domain formation. Langmuir : the Acs Journal of Surfaces and Colloids. 31: 5093-104. PMID 25876023 DOI: 10.1021/la504923j  1
2015 Mellott AJ, Devarajan K, Shinogle HE, Moore DS, Talata Z, Laurence JS, Forrest ML, Noji S, Tanaka E, Staecker H, Detamore MS. Nonviral Reprogramming of Human Wharton's Jelly Cells Reveals Differences Between ATOH1 Homologues. Tissue Engineering. Part A. 21: 1795-809. PMID 25760435 DOI: 10.1089/ten.TEA.2014.0340  1
2015 Thati S, Kuehl C, Hartwell B, Sestak J, Siahaan T, Forrest ML, Berkland C. Routes of administration and dose optimization of soluble antigen arrays in mice with experimental autoimmune encephalomyelitis. Journal of Pharmaceutical Sciences. 104: 714-21. PMID 25447242 DOI: 10.1002/jps.24272  1
2015 Ramsey JD, Forrest ML. Foreword: Nanoparticles for biotherapeutic delivery Nanoparticles For Biotherapeutic Delivery. 1: 2-4. DOI: 10.4155/9781910420409.FSEB2013.14.382  1
2015 Ramsey JD, Forrest ML. Nanoparticles for biotherapeutic delivery Nanoparticles For Biotherapeutic Delivery. 2: 1-131. DOI: 10.4155/ 9781910420430  1
2014 Sestak JO, Sullivan BP, Thati S, Northrup L, Hartwell B, Antunez L, Forrest ML, Vines CM, Siahaan TJ, Berkland C. Codelivery of antigen and an immune cell adhesion inhibitor is necessary for efficacy of soluble antigen arrays in experimental autoimmune encephalomyelitis. Molecular Therapy. Methods & Clinical Development. 1: 14008. PMID 26015953 DOI: 10.1038/mtm.2014.8  1
2014 Cai S, Alhowyan AA, Yang Q, Forrest WC, Shnayder Y, Forrest ML. Cellular uptake and internalization of hyaluronan-based doxorubicin and cisplatin conjugates. Journal of Drug Targeting. 22: 648-57. PMID 24892741 DOI: 10.3109/1061186X.2014.921924  1
2014 Louizos C, Yáñez JA, Forrest ML, Davies NM. Understanding the hysteresis loop conundrum in pharmacokinetic/pharmacodynamic relationships. Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society For Pharmaceutical Sciences, SociéTé Canadienne Des Sciences Pharmaceutiques. 17: 34-91. PMID 24735761  1
2014 Zhao Y, Zhang T, Duan S, Davies NM, Forrest ML. CD44-tropic polymeric nanocarrier for breast cancer targeted rapamycin chemotherapy. Nanomedicine : Nanotechnology, Biology, and Medicine. 10: 1221-30. PMID 24637218 DOI: 10.1016/j.nano.2014.02.015  1
2014 Yang Q, Aires DJ, Cai S, Fraga GR, Zhang D, Li CZ, Forrest ML. In vivo efficacy of nano hyaluronan-conjugated cisplatin for treatment of murine melanoma. Journal of Drugs in Dermatology : Jdd. 13: 283-7. PMID 24595572  0.36
2014 Mellott AJ, Godsey ME, Shinogle HE, Moore DS, Forrest ML, Detamore MS. Improving viability and transfection efficiency with human umbilical cord wharton's jelly cells through use of a ROCK inhibitor. Cellular Reprogramming. 16: 91-7. PMID 24552552 DOI: 10.1089/cell.2013.0069  1
2013 Zhang T, Cui H, Fang CY, Jo J, Yang X, Chang HC, Forrest ML. In vivo photoacoustic imaging of breast cancer tumor with HER2-targeted nanodiamonds. Proceedings of Spie--the International Society For Optical Engineering. 8815. PMID 25620857 DOI: 10.1117/12.2027253  1
2013 Cohen SM, Rockefeller N, Mukerji R, Durham D, Forrest ML, Cai S, Cohen MS, Shnayder Y. Efficacy and toxicity of peritumoral delivery of nanoconjugated cisplatin in an in vivo murine model of head and neck squamous cell carcinoma. Jama Otolaryngology-- Head & Neck Surgery. 139: 382-7. PMID 23599074 DOI: 10.1001/jamaoto.2013.214  1
2013 Zhang T, Cui H, Fang CY, Su LJ, Ren S, Chang HC, Yang X, Forrest ML. Photoacoustic contrast imaging of biological tissues with nanodiamonds fabricated for high near-infrared absorbance. Journal of Biomedical Optics. 18: 26018. PMID 23400417 DOI: 10.1117/1.JBO.18.2.026018  1
2013 Devarajan K, Forrest ML, Detamore MS, Staecker H. Adenovector-mediated gene delivery to human umbilical cord mesenchymal stromal cells induces inner ear cell phenotype. Cellular Reprogramming. 15: 43-54. PMID 23379581 DOI: 10.1089/cell.2011.0097  1
2013 Mellott AJ, Forrest ML, Detamore MS. Physical non-viral gene delivery methods for tissue engineering. Annals of Biomedical Engineering. 41: 446-68. PMID 23099792 DOI: 10.1007/s10439-012-0678-1  1
2012 Duan S, Cai S, Xie Y, Bagby T, Ren S, Forrest ML. Synthesis and characterization of a multi-arm poly(acrylic acid) star polymer for application in sustained delivery of cisplatin and a nitric oxide prodrug. Journal of Polymer Science. Part a, Polymer Chemistry. 50: 2715-2724. PMID 26549934 DOI: 10.1002/pola.26059  1
2012 Remsberg CM, Zhao Y, Takemoto JK, Bertram RM, Davies NM, Forrest ML. Pharmacokinetic Evaluation of a DSPE-PEG2000 Micellar Formulation of Ridaforolimus in Rat. Pharmaceutics. 5: 81-93. PMID 24300398 DOI: 10.3390/pharmaceutics5010081  1
2012 Ndolo RA, Luan Y, Duan S, Forrest ML, Krise JP. Lysosomotropic properties of weakly basic anticancer agents promote cancer cell selectivity in vitro. Plos One. 7: e49366. PMID 23145164 DOI: 10.1371/journal.pone.0049366  1
2012 Mohamed EA, Zhao Y, Meshali MM, Remsberg CM, Borg TM, Foda AM, Takemoto JK, Sayre CL, Martinez SE, Davies NM, Forrest ML. Vorinostat with sustained exposure and high solubility in poly(ethylene glycol)-b-poly(DL-lactic acid) micelle nanocarriers: characterization and effects on pharmacokinetics in rat serum and urine. Journal of Pharmaceutical Sciences. 101: 3787-98. PMID 22806441 DOI: 10.1002/jps.23265  1
2012 Zhao Y, Duan S, Zeng X, Liu C, Davies NM, Li B, Forrest ML. Prodrug strategy for PSMA-targeted delivery of TGX-221 to prostate cancer cells. Molecular Pharmaceutics. 9: 1705-16. PMID 22494444 DOI: 10.1021/mp3000309  1
2012 Duan S, Cai S, Yang Q, Forrest ML. Multi-arm polymeric nanocarrier as a nitric oxide delivery platform for chemotherapy of head and neck squamous cell carcinoma. Biomaterials. 33: 3243-53. PMID 22281420 DOI: 10.1016/j.biomaterials.2012.01.026  1
2012 Shum VW, Gabrielson NP, Forrest ML, Pack DW. The effects of PVP(Fe(III)) catalyst on polymer molecular weight and gene delivery via biodegradable cross-linked polyethylenimine. Pharmaceutical Research. 29: 500-10. PMID 21892707 DOI: 10.1007/s11095-011-0576-5  1
2012 Hart DS, Zhao Y, Forrest ML. Polyethylene glycol polyester block copolymers: Biocompatible carriers for nanoparticulate drug delivery Handbook of Harnessing Biomaterials in Nanomedicine. 43-75. DOI: 10.4032/9789814364270  1
2012 Yang Q, Cui H, Cai S, Yang X, Forrest ML. Photoacoustic imaging of chemotherapy-induced apoptosis in squamous cell carcinoma Progress in Biomedical Optics and Imaging - Proceedings of Spie. 8223. DOI: 10.1117/12.908943  1
2011 Luan Y, Yang Q, Xie Y, Duan S, Cai S, Forrest ML. A sensitive near-infrared fluorescent probe for caspase-mediated apoptosis: Synthesis and application in cell imaging. Drug Discoveries & Therapeutics. 5: 220-226. PMID 22282719 DOI: 10.5582/ddt.2011.v5.5.220  0.36
2011 Cai S, Bagby TR, Forrest ML. Development of regional chemotherapies: feasibility, safety and efficacy in clinical use and preclinical studies. Therapeutic Delivery. 2: 1467-84. PMID 22229080 DOI: 10.4155/tde.11.112  1
2011 Yang Q, Cui H, Cai S, Yang X, Forrest ML. In vivo photoacoustic imaging of chemotherapy-induced apoptosis in squamous cell carcinoma using a near-infrared caspase-9 probe. Journal of Biomedical Optics. 16: 116026. PMID 22112131 DOI: 10.1117/1.3650240  1
2011 Cohen SM, Mukerji R, Cai S, Damjanov I, Forrest ML, Cohen MS. Subcutaneous delivery of nanoconjugated doxorubicin and cisplatin for locally advanced breast cancer demonstrates improved efficacy and decreased toxicity at lower doses than standard systemic combination therapy in vivo. American Journal of Surgery. 202: 646-52; discussion 6. PMID 21982998 DOI: 10.1016/j.amjsurg.2011.06.027  1
2011 Yáñez JA, Remsberg CM, Sayre CL, Forrest ML, Davies NM. Flip-flop pharmacokinetics--delivering a reversal of disposition: challenges and opportunities during drug development. Therapeutic Delivery. 2: 643-72. PMID 21837267 DOI: 10.4155/tde.11.19  1
2011 Nune SK, Gunda P, Majeti BK, Thallapally PK, Forrest ML. Advances in lymphatic imaging and drug delivery. Advanced Drug Delivery Reviews. 63: 876-85. PMID 21718728 DOI: 10.1016/j.addr.2011.05.020  1
2011 Cai S, Yang Q, Bagby TR, Forrest ML. Lymphatic drug delivery using engineered liposomes and solid lipid nanoparticles. Advanced Drug Delivery Reviews. 63: 901-8. PMID 21712055 DOI: 10.1016/j.addr.2011.05.017  1
2011 Cohen MS, Forrest ML. Lymphatic drug delivery: therapy, imaging and nanotechnology. Preface. Advanced Drug Delivery Reviews. 63: 865-6. PMID 21669240 DOI: 10.1016/j.addr.2011.05.013  1
2010 Cai S, Xie Y, Davies NM, Cohen MS, Forrest ML. Carrier-based intralymphatic cisplatin chemotherapy for the treatment of metastatic squamous cell carcinoma of the head & neck. Therapeutic Delivery. 1: 237-45. PMID 21339844 DOI: 10.4155/tde.10.38  1
2010 Ndolo RA, Jacobs DT, Forrest ML, Krise JP. Intracellular Distribution-based Anticancer Drug Targeting: Exploiting a Lysosomal Acidification Defect Associated with Cancer Cells. Molecular and Cellular Pharmacology. 2: 131-136. PMID 21274418 DOI: 10.4255/mcpharmacol.10.18  1
2010 Xie Y, Aillon KL, Cai S, Christian JM, Davies NM, Berkland CJ, Forrest ML. Pulmonary delivery of cisplatin-hyaluronan conjugates via endotracheal instillation for the treatment of lung cancer. International Journal of Pharmaceutics. 392: 156-63. PMID 20363303 DOI: 10.1016/j.ijpharm.2010.03.058  1
2010 Ndolo RA, Forrest ML, Krise JP. The role of lysosomes in limiting drug toxicity in mice. The Journal of Pharmacology and Experimental Therapeutics. 333: 120-8. PMID 20056778 DOI: 10.1124/jpet.109.160226  1
2010 Cai S, Xie Y, Davies NM, Cohen MS, Forrest ML. Pharmacokinetics and disposition of a localized lymphatic polymeric hyaluronan conjugate of cisplatin in rodents. Journal of Pharmaceutical Sciences. 99: 2664-71. PMID 19960530 DOI: 10.1002/jps.22016  1
2010 Rao DA, Forrest ML, Alani AW, Kwon GS, Robinson JR. Biodegradable PLGA based nanoparticles for sustained regional lymphatic drug delivery. Journal of Pharmaceutical Sciences. 99: 2018-31. PMID 19902520 DOI: 10.1002/jps.21970  1
2009 Cohen MS, Cai S, Xie Y, Forrest ML. A novel intralymphatic nanocarrier delivery system for cisplatin therapy in breast cancer with improved tumor efficacy and lower systemic toxicity in vivo. American Journal of Surgery. 198: 781-6. PMID 19969129 DOI: 10.1016/j.amjsurg.2009.07.032  1
2009 Xie Y, Bagby TR, Cohen MS, Forrest ML. Drug delivery to the lymphatic system: importance in future cancer diagnosis and therapies. Expert Opinion On Drug Delivery. 6: 785-92. PMID 19563270 DOI: 10.1517/17425240903085128  1
2009 Aillon KL, Xie Y, El-Gendy N, Berkland CJ, Forrest ML. Effects of nanomaterial physicochemical properties on in vivo toxicity. Advanced Drug Delivery Reviews. 61: 457-66. PMID 19386275 DOI: 10.1016/j.addr.2009.03.010  1
2009 Xiong MP, Yáñez JA, Kwon GS, Davies NM, Forrest ML. A cremophor-free formulation for tanespimycin (17-AAG) using PEO-b-PDLLA micelles: characterization and pharmacokinetics in rats. Journal of Pharmaceutical Sciences. 98: 1577-86. PMID 18752263 DOI: 10.1002/jps.21509  1
2008 Cai S, Xie Y, Bagby TR, Cohen MS, Forrest ML. Intralymphatic chemotherapy using a hyaluronan-cisplatin conjugate. The Journal of Surgical Research. 147: 247-52. PMID 18498877 DOI: 10.1016/j.jss.2008.02.048  1
2008 Xiong MP, Yáñez JA, Remsberg CM, Ohgami Y, Kwon GS, Davies NM, Forrest ML. Formulation of a geldanamycin prodrug in mPEG-b-PCL micelles greatly enhances tolerability and pharmacokinetics in rats. Journal of Controlled Release : Official Journal of the Controlled Release Society. 129: 33-40. PMID 18456363 DOI: 10.1016/j.jconrel.2008.03.015  1
2008 Forrest ML, Kwon GS. Clinical developments in drug delivery nanotechnology. Advanced Drug Delivery Reviews. 60: 861-2. PMID 18358557 DOI: 10.1016/j.addr.2008.02.013  1
2008 Vega-Villa KR, Takemoto JK, Yáñez JA, Remsberg CM, Forrest ML, Davies NM. Clinical toxicities of nanocarrier systems. Advanced Drug Delivery Reviews. 60: 929-38. PMID 18313790 DOI: 10.1016/j.addr.2007.11.007  1
2008 Forrest ML, Yáñez JA, Remsberg CM, Ohgami Y, Kwon GS, Davies NM. Paclitaxel prodrugs with sustained release and high solubility in poly(ethylene glycol)-b-poly(epsilon-caprolactone) micelle nanocarriers: pharmacokinetic disposition, tolerability, and cytotoxicity. Pharmaceutical Research. 25: 194-206. PMID 17912488 DOI: 10.1007/s11095-007-9451-9  1
2008 Yáñez JA, Forrest ML, Ohgami Y, Kwon GS, Davies NM. Pharmacometrics and delivery of novel nanoformulated PEG-b-poly(epsilon-caprolactone) micelles of rapamycin. Cancer Chemotherapy and Pharmacology. 61: 133-44. PMID 17393166 DOI: 10.1007/s00280-007-0458-z  1
2007 Xiong MP, Forrest ML, Ton G, Zhao A, Davies NM, Kwon GS. Poly(aspartate-g-PEI800), a polyethylenimine analogue of low toxicity and high transfection efficiency for gene delivery. Biomaterials. 28: 4889-900. PMID 17692910 DOI: 10.1016/j.biomaterials.2007.07.043  0.52
2007 Xiong MP, Bae Y, Fukushima S, Forrest ML, Nishiyama N, Kataoka K, Kwon GS. pH-responsive Multi-PEGylated dual cationic nanoparticles enable charge modulations for safe gene delivery. Chemmedchem. 2: 1321-7. PMID 17579918 DOI: 10.1002/cmdc.200700093  1
2007 Xiong MP, Forrest ML, Karls AL, Kwon GS. Biotin-triggered release of poly(ethylene glycol)-avidin from biotinylated polyethylenimine enhances in vitro gene expression. Bioconjugate Chemistry. 18: 746-53. PMID 17375897 DOI: 10.1021/bc0602883  1
2006 Forrest ML, Zhao A, Won CY, Malick AW, Kwon GS. Lipophilic prodrugs of Hsp90 inhibitor geldanamycin for nanoencapsulation in poly(ethylene glycol)-b-poly(epsilon-caprolactone) micelles. Journal of Controlled Release : Official Journal of the Controlled Release Society. 116: 139-49. PMID 16926059 DOI: 10.1016/j.jconrel.2006.07.003  1
2006 Forrest ML, Won CY, Malick AW, Kwon GS. In vitro release of the mTOR inhibitor rapamycin from poly(ethylene glycol)-b-poly(epsilon-caprolactone) micelles. Journal of Controlled Release : Official Journal of the Controlled Release Society. 110: 370-7. PMID 16298448 DOI: 10.1016/j.jconrel.2005.10.008  1
2006 Kwon GS, Forrest ML. Amphiphilic block copolymer micelles for nanoscale drug delivery Drug Development Research. 67: 15-22. DOI: 10.1002/ddr.20063  1
2005 Forrest ML, Gabrielson N, Pack DW. Cyclodextrin-polyethylenimine conjugates for targeted in vitro gene delivery. Biotechnology and Bioengineering. 89: 416-23. PMID 15627256 DOI: 10.1002/bit.20356  1
2005 Forrest ML, Kwon GS. A novel serum-stable micelle system for controlled release of rapamycin Aiche Annual Meeting, Conference Proceedings. 8875.  1
2005 Forrest ML, Kwon GS. Hydrolysable prodrugs of geldanamycin for efficient nanoencapsulation and sustained release Aiche Annual Meeting, Conference Proceedings. 8885.  1
2005 Forrest ML, Pack DW, Kwon GS. Nanocarriers for controlled delivery of therapeutic agents Aiche Annual Meeting, Conference Proceedings. 3344.  1
2004 Forrest ML, Meister GE, Koerber JT, Pack DW. Partial acetylation of polyethylenimine enhances in vitro gene delivery. Pharmaceutical Research. 21: 365-71. PMID 15032320 DOI: 10.1023/B:PHAM.0000016251.42392.1e  1
2003 Forrest ML, Koerber JT, Pack DW. A degradable polyethylenimine derivative with low toxicity for highly efficient gene delivery. Bioconjugate Chemistry. 14: 934-40. PMID 13129396 DOI: 10.1021/bc034014g  1
2002 Forrest ML, Pack DW. On the kinetics of polyplex endocytic trafficking: implications for gene delivery vector design. Molecular Therapy : the Journal of the American Society of Gene Therapy. 6: 57-66. PMID 12095304 DOI: 10.1006/mthe.2002.0631  1
Show low-probability matches.